The study aims to investigate the mechanism of quercetin in inhibiting porcine reproductive and respiratory syndrome virus (PRRSV)-induced inflammation.
Twenty-eightday-old piglets were randomly divided into four groups: PRRSV group, PRRSV+low-dose quercetin (12.5 mg/kg basal diet), PRRSV+medium-dose quercetin (25 mg/kg basal diet), and PRRSV+high-dose quercetin (50 mg/kg basal diet). A blank control group was also established. Serum samples were collected at 7, 14, and 35 days after infection to determine serum inflammatory factors in each group. Pig lungs were collected to detect tissue lesions after 35 days of infection. The metabolic profiles of pig serum were analyzed, and the differential metabolites and related metabolic pathways were identified. A “ingredient-target-pathway-disease” diagram of inflammation for quercetin treatment was constructed by network pharmacology. The molecular docking method was used to verify the interaction between the active ingredients and the core targets. Serum metabolomics and network pharmacology were combined to construct a “target-metabolic pathway-metabolite” network diagram. The expression of key regulatory targets phospholipase A2 (PLA2), cyclooxygenase (COX), and lipoxygenase (LOX) mRNA was detected.
Compared with the blank control group, piglets in the PRRSV group exhibited significant or extremely significant increases (P<0.05 or P<0.01) in serum inflammatory cytokines and pulmonary inflammatory cytokine mRNA from 7 to 35 days post-infection. In contrast, quercetin treatments at different concentrations significantly suppressed (P<0.05 or P<0.01) the expression levels of serum inflammatory cytokines, pulmonary inflammatory cytokine mRNA, and PRRSV N gene compared to the PRRSV group. Histopathological analysis revealed that quercetin alleviated PRRSV-induced interstitial pneumonia. Through metabolomics techniques, five key metabolic pathways (glyceryl ester metabolism, ether lipid metabolism, glycerophospholipid metabolism, tyrosine metabolism, and arachidonic acid metabolism) and 16 differential metabolites in serum were identified. Compared with the PRRSV group, quercetin was able to reverse the levels of these differential metabolites. Network pharmacology analysis showed that quercetin mainly acted on target proteins such as EGFR, MMP9, PTGS2, CDK2, and APP in interstitial pneumonia treatment, which were closely linked to metabolic pathways, PI3K-Akt signaling pathways, IL-17 signaling pathways, and T cell receptor signaling pathways. Integrated analysis demonstrated glycerophospholipid metabolism and arachidonic acid metabolism as key metabolic pathways for quercetin treatment of interstitial pneumonia. The integrated verification results confirmed that the pulmonary mRNA expression levels of PLA2, COX1 and LOX in the quercetin groups were mostly significantly or extremely significantly reduced (P< 0.05 or P<0.01) compared with the PRRSV group.
Quercetin can regulate serum metabolites and inflammation-related core targets through glycerophospholipid metabolism and arachidonic acid metabolism pathways, reduce inflammation levels, alleviate metabolic disorders, and play a therapeutic role in interstitial pneumonia.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |